Patrizia Elva Aguilar-Calderón

Patrizia Elva Aguilar-Calderón

Auto-generated profile, based on publicly available information

Patrizia Elva Aguilar-Calderón

Department of Dermatology Hospital Universitario Dr. José E. González Monterrey Nuevo León Mexico

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Journal of Blood Medicine
Verified
Journal Article
Open access
PDF file
JJJosé Carlos Jaime-Pérez
José Carlos Jaime-Pérez
PAPatrizia Elva Aguilar-Calderón
Patrizia Elva Aguilar-Calderón
LSLorena Salazar-Cavazos
Lorena Salazar-Cavazos
DGDavid Gómez-Almaguer
David Gómez-Almaguer
Evans syndrome (ES) is a rare and chronic autoimmune disease characterized by autoimmune hemolytic anemia and immune thrombocytopenic purpura with a positive direct anti-human globulin test. It is classified as primary and secondary, with the frequency in patients with autoimmune hemolytic anemia being 37%–73%. It predominates in children, mainly due to primary immunodeficiencies or autoimmune lymphoproliferative syndrome. ES during pregnancy is associated with high fetal morbidity, including severe hemolysis and intracranial bleeding with neurological sequelae and death. The clinical presentation can include fatigue, pallor, jaundice and mucosal bleeding, with remissions and exacerbations during the person’s lifetime, and acute manifestations as catastrophic bleeding and massive hemolysis. Recent molecular theories explaining the physiopathology of ES include deficiencies of CTLA-4, LRBA, TPP2 and a decreased CD4/CD8 ratio. As in other autoimmune cytopenias, there is no established evidence-based treatment and steroids are the first-line therapy, with intravenous immunoglobulin administered as a life-saving resource in cases of severe immune thrombocytopenic purpura manifestations. Second-line treatment for refractory ES includes rituximab, mofetil mycophenolate, cyclosporine, vincristine, azathioprine, sirolimus and thrombopoietin receptor agonists. In cases unresponsive to immunosuppressive agents, hematopoietic stem cell transplantation has been successful, although it is necessary to consider its potential serious adverse effects. In conclusion, ES is a disease with a heterogeneous course that remains challenging to patients and physicians, with prospective clinical trials needed to explore potential targeted therapy to achieve an improved long-term response or even a cure.

30 June 2019 in Blood Research
Verified
Journal Article
Open access
PDF file
JJJosé Carlos Jaime-Pérez
José Carlos Jaime-Pérez
PAPatrizia Aguilar-Calderón
Patrizia Aguilar-Calderón
LSLorena Salazar-Cavazos
Lorena Salazar-Cavazos
ALAndrés Gómez-De León
Andrés Gómez-De León
DGDavid Gómez-Almaguer
David Gómez-Almaguer
Jaime-Pérez JC, et al. Blood Res. 2019 Jun;54(2):131-136. https://doi.org/10.5045/br.2019.54.2.131

21 September 2018 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
JJJosé Carlos Jaime-Pérez
José Carlos Jaime-Pérez
LSLorena Salazar-Cavazos
Lorena Salazar-Cavazos
PAPatrizia Aguilar-Calderón
Patrizia Aguilar-Calderón
JHJosé Luis Herrera-Garza
José Luis Herrera-Garza
CGCesar Homero Gutierrez-Aguirre
Cesar Homero Gutierrez-Aguirre
DGDavid Gómez-Almaguer
David Gómez-Almaguer

13 May 2024 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
ACAdrian Cuellar-Barboza
Adrian Cuellar-Barboza
EBElizabeth Brussolo-Marroquín
Elizabeth Brussolo-Marroquín
FCFanny C Cordero-Martinez
Fanny C Cordero-Martinez
PAPatrizia E Aguilar-Calderon
Patrizia E Aguilar-Calderon
OVOsvaldo Vazquez-Martinez
Osvaldo Vazquez-Martinez
JOJorge Ocampo-Candiani
Jorge Ocampo-Candiani
Background: ChatGPT is an open-access chatbot developed using artificial intelligence (AI) that generates human-like responses. Objective: To evaluate the ChatGPT-4’s concordance with three dermatological surgeons on reconstructions for dermatological surgical defects. Methods: The cases of 70 patients with nonmelanoma skin cancer treated with surgery were obtained from clinical records for analysis. A list of 30 reconstruction options was designed by the main authors that included primary closure, secondary skin closure, skin flaps and skin grafts. Three dermatological surgeons who were blinded to the real reconstruction, along with ChatGPT-4, were asked to select two reconstruction options from the list. Results: Seventy responses were analysed using Cohen’s kappa, looking for concordance between each dermatologist and ChatGPT. The level of agreement among dermatological surgeons was higher compared with that between dermatological surgeons and ChatGPT, highlighting differences in decision making. In the selection of the best reconstruction technique, the results indicated a fair level of agreement among the dermatologists, ranging between κ 0.268 and 0.331. However, the concordance between ChatGPT-4 and the dermatologists was slight, with κ values ranging from 0.107 to 0.121. In the analysis of the second-choice options, the dermatologists showed only slight agreement. In contrast, the level of concordance between ChatGPT-4 and the dermatologists was below chance. Conclusions: As anticipated, this study reveals variability in medical decisions between dermatological surgeons and ChatGPT. Although these tools offer exciting possibilities for the future, it is vital to acknowledge the risk of inadvertently relying on noncertified AI for medical advice.

16 July 2018 in Hematology
Verified
Journal Article
Closed access
JJJosé Carlos Jaime-Pérez
José Carlos Jaime-Pérez
GTGoel Trevino
Goel Trevino
PAPatrizia Aguilar-Calderón
Patrizia Aguilar-Calderón
OCOlga G. Cantú-Rodríguez
Olga G. Cantú-Rodríguez
LMLuis Javier Marfil-Rivera
Luis Javier Marfil-Rivera
DGDavid Gómez-Almaguer
David Gómez-Almaguer
Objectives: To demonstrate the importance of regional efforts to register features and report frequency of hematology diseases in the context of incomplete national registries. Methods: Frequencies and salient characteristics of hematologic diseases in Northeast Mexico were documented in a reference center at a tertiary care university hospital during the decade 2005–2015. Disease categories were grouped by age, sex and diagnosis. Age group distribution followed WHO guidelines in years as children (0–17), adults (18–64) and elders (+65). Results: 2406 patients were included: 1239 (51.5%) were females and 1167 (48.5%) males; F:M ratio was 1.06:1; median age was 35 years (0–95). The frequency by age group included adults, 1370 cases (56.9%), children, 695 cases (28.9%), and elderly, 341 (14.2%). Most frequent diagnoses were acute lymphoblastic leukemia (ALL) 18.2% (<i>n</i> = 438), anemia 15.9% (<i>n</i> = 383), non-Hodgkin’s lymphoma (NHL) 15.7% (<i>n</i> = 378), immune thrombocytopenic purpura (ITP) 9.8% (<i>n</i> = 235) and Hodgkin’s lymphoma (HL) 6.5% (<i>n</i> = 156). Median age for the whole cohort was 35 years; for children, was 6 years, for adults 40 and for the elderly 73. Results for ALL, anemia and ITP were comparable to high-income countries; NHL, HL and chronic myeloid leukemia presented a decade earlier. Discussion: Complete, opportune reliable information on the number of cases, age and sex distribution with the potential to influence strategies for timely diagnosis and treatment options for important hematologic diseases can be accrued by regional centers. Conclusion: Information on hematology diseases derived of regional registries in low-middle income countries is a reasonable alternative to complement and update national registries.

20 December 2023 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
PAPatrizia E Aguilar-Calderón
Patrizia E Aguilar-Calderón
LGLeslie M Garza-García
Leslie M Garza-García
EBElizabeth Brussolo-Marroquín
Elizabeth Brussolo-Marroquín
ACAdrian Cuellar-Barboza
Adrian Cuellar-Barboza
JOJorge Ocampo-Candiani
Jorge Ocampo-Candiani
LFLucía T Fernández
Lucía T Fernández
A 27-year-old male traveller returning from the Amazon forest came to our dermatology consultation with a furuncle-like nodule in the temporal region. During examination we observed an erythematous nodule with a central opening. We describe the entodermoscopic characteristics of Dermatobia hominis.